- ·2 fund marks: filer, period, implied $/share
Membership and data by Private Market View
Eikon Therapeutics (NAS: EIKN) funding history
No funding rounds for Eikon Therapeutics (NAS: EIKN) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Eikon Therapeutics (NAS: EIKN) valuation
Eikon Therapeutics (NAS: EIKN) is now publicly traded; this page covers its private-market history, where its last recorded valuation was $972 million (Feb 2026). Secondary trades, fund marks and rounds below are the private-market record; the listed share price is not tracked here.
Institutional holders and vehicles
1 SEC-registered fund reported 2 fair-value marks on Eikon Therapeutics (NAS: EIKN) between Feb 2026 and May 2026, in their N-PORT filings. Filer-level marks and implied per-share values are available to Pro members.
How Eikon Therapeutics (NAS: EIKN)'s valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Eikon Therapeutics (NAS: EIKN), too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked about Eikon Therapeutics (NAS: EIKN)
- What is Eikon Therapeutics (NAS: EIKN) worth?
- Eikon Therapeutics (NAS: EIKN)'s last known valuation is $971.7M.
- How much has Eikon Therapeutics (NAS: EIKN) raised?
- Eikon Therapeutics (NAS: EIKN) has raised $1.5B in total funding across its recorded rounds.